Antimicrobial Resistance in Gram-Negative Hospital Isolates: Results of the Turkish HITIT-2 Surveillance Study of 2007

REFERENCES

• Paterson DL, Ko WC, Gottberg AV, Casellas JM, Mulazi-moglu L, Klugman K, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing Extended-Spectrum 13-Lactamases: implications for the Clinical Microbiology Laboratory. J Clin Microbiol 2001; 39: 2206-2212.
   Google Scholar
• Livermore DM. Bacterial resistance: Origins, epidemiology and impact. Clin Infect Dis 2003; 36(Suppl 1): 11–23.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum 13-lacta-mases: a clinical update. Clin Microbiol Rev 2005; 18: 657–686.
   PubMed Web of Science ®Google Scholar
• Tenover FC. Mechanisms of antimicrobial resistance in bac-teria. Am J Infect Control. 2006; 34(5 Suppl 1):53-10.
   Google Scholar
• Masterton RG. Surveillance studies:how can they help the management of infection? J Antimicrob Chemother 2000; 46: 53–58.
   Web of Science ®Google Scholar
• Lewis D. Antimicrobial resistance surveillance: methods will depend on objectives. J Antimicrob Chemother 2002; 49: 3–5.
   PubMed Web of Science ®Google Scholar
• Morris AK, Masterton RG. Antibiotic resistance surveil-lance: action for international studies. J Antimicrob Chemother 2002; 49: 7–10.
   PubMed Web of Science ®Google Scholar
• Gtir D, Gtilay Z, Arikan Akan O, et al. Resistance to newer 13-lactams and related ESBL types in gram negative nosocomial isolates in Turkish hospitals— results of the multicenter HITIT study. Turk Mikrobiyol BuIt 2008; 42 (4): 537–544.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute/NCCLS. Per-formance Standards for Antimicrobial Susceptibility Testing-Sev-enteenth Informational Supplement. CLSI/NCCLS document M100-517. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA, 2007.
   Google Scholar
• Barry AL, Jones RN and The Collaborative Antimicrobial Susceptibility Testing Group. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination. J Clin Microbiol 1988; 26: 13–17.
   Google Scholar
• Bax R, Bywater R, Cornaglia G, Goossens H, Hunter P Isham V, et al. Surveillance of antimicrobial resistance-what, how and whither? Clin Microbiol Infect 2001; 7: 316–325.
   Google Scholar
• Over U, Gur D, ()nal S, Miller GH, Aminoglycoside Resistance Study Group. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect 2001; 7: 470–478.
   Google Scholar
• Gur D, Tutar I, Vardar-OnIti G, Unit) M, Ozinel MA, Stimerkan B, et al. The in vitro efficacy of isepamicin against Gram-negative hospital isolates. Turkish J Hosp Infect 2001; 5:Suppl 1: 19–24.
   Google Scholar
• Leblebicioglu H, Gunaydin M, Esen S, Tuncer I, Findik D, Ural O, et al. Surveillance of antimicrobial resistance in gram-negative isolates from intensive care units in Turkey: Analysis of data from the last 5 years. J Chemother 2002; 14 (2): 140–146.
   PubMed Web of Science ®Google Scholar
• Borg MA, van de Sande-Bruinsma N, Scicluna E, de Kraker M, Tiemersma E, Monen J, Grundmann H, on behalf of the ARMed Project members and collaborators. Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect 2008; 14: 789–796.
   Google Scholar
• Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet In-fect dis 2006; 6: 629–640.
   PubMed Web of Science ®Google Scholar
• Oktem MA, allay Z, Bignen M, Gur D and the HITIT Project Study Group. qnrA prevalence in extended-spectrum 13-lactamase positive Enterobacteriaceae isolates from Turkey. JpnJ Infect Dis 2008; 61: 13–17.
   Google Scholar
• Poirel L, Gur D, Minarini L, Arslan U, Nordmann P. on behalf of the Turkish Study Group on ESBL/Qnr relationships. Molecular epidemiology of plasmid-mediated quinolone resist-ance determinants in extended-spectrum 13-lactamase producing Escherichia coil and Klebsiella pneumoniae isolates from Turkey. 18th ECCMID Poster no: 1527, April 19-22, 2008, Barcelona, Spain.
   Google Scholar
• The Turkish Antimicrobial Resistance Study Group, Pfaller MA, Korten V, Jones RN, Doern G. Multicenter evaluation of the antimicrobial activity for seven broad-spectrum 13-lactamas in Turkey using the Etest method. Diagn Microbiol Infect Dis 1999; 35: 65–73.
   PubMed Web of Science ®Google Scholar
• Jones RN, Pfaller MA and the MYSTIC Study Group (Eu-rope). Antimicrobial activity against strains of Escherichia coil and Klebsiella spp. with resistance phenotypes consistent with an extended-spectrum 13-lactamase in Europe. Clin Microbiol In-fect 2003; 9: 708–712.
   Google Scholar
• Srinivasan A, Patel JB. Klebsiella pneumoniae car-bapenemase-producing organisms: An ounce of prevention really is worth a pound of cure. Infect Control Hosp Epidemiol 2008, 29 (12): 1107–1109.
   PubMed Web of Science ®Google Scholar
• Walsh TR. Clinically significant carbapenemases: an up-date. Curr Opin Infect Dis 2008; 21: 367–371.
   PubMed Web of Science ®Google Scholar
• Qeenan AM, Bush K. Carbapenemases: the versatile 13-lactamases. Clin Microbiol Rev 2007; 20: 440–458.
   PubMed Web of Science ®Google Scholar
• Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacilliase-mediated resistance to imipenem in Klebsiella pneu-moniae. Antimicrob Agents Chemother 2004; 48: 15–22.
   PubMed Web of Science ®Google Scholar
• Aktas Z, Bal C, Midilli K, Poirel L, Nordmann P. First IMP-1-producing Klebsiella pneumoniae isolate in Turkey. Clin Mi-crobiol Infect 2006; 695–696.
   PubMed Web of Science ®Google Scholar
• Yildirim, Ceyhan M, Gtir D, Mugnaioli C, Rossolini GM. First detection of VIM-1 type metallo-beta-lactamase in a mul-tidrug-resistant Klebsiella pneumoniae clinical isolate from Turkey also producing the CTX-M-15 extended-spectrum beta-lactamase. J Chemother 2007; 19 (4): 467–8.
   PubMed Web of Science ®Google Scholar
• Aktas Z, Kayacan Bal C, Schneider I, Can B, Midilli K, Bauernfeind A. carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy 2008; 54: 101–106.
   PubMed Web of Science ®Google Scholar
• Gulmez D, Woodford N, Palepou MFI, Mushtaq S, Metan G, Yakupogullari Y, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J An-timicrob Agents 2008; 31: 523–526.
   PubMed Web of Science ®Google Scholar
• Ishii Y, Alba J, Kimura S, Yamaguchi K. Evaluation of an-timicrobial activity of 13-lactam antibiotics by Etest against clinical isolates from 100 medical centers in Japan (2004). Diagn Mi-crobiol Infect Dis 2006; 55 (2): 143–148.
   PubMed Web of Science ®Google Scholar
• Fu W, Demei Z, Shi W, Fupin H, Yingyuan Z. The sus-ceptibility of non-fermentative Gram negative bacilli to cefoper-azone and sulbactam compared with other bacterial agents. Int J Antimicrob Agents 2003; 22: 444–448.
   PubMed Web of Science ®Google Scholar